206 related articles for article (PubMed ID: 22558085)
1. Lymphocyte modulation with FTY720 improves hemorrhagic shock survival in swine.
Hawksworth JS; Graybill JC; Brown TS; Wallace SM; Davis TA; Tadaki DK; Elster EA
PLoS One; 2012; 7(4):e34224. PubMed ID: 22558085
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte depletion in experimental hemorrhagic shock in Swine.
Hawksworth JS; Graybill C; Brown TS; Gillern SM; Wallace SM; Davis TA; Elster EA; Tadaki DK
J Inflamm (Lond); 2012 Sep; 9(1):34. PubMed ID: 23009382
[TBL] [Abstract][Full Text] [Related]
3. FTY720, a novel immunosuppressant, induces sequestration of circulating lymphocytes by acceleration of lymphocyte homing.
Chiba K; Yanagawa Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
Transplant Proc; 1999; 31(1-2):1230-3. PubMed ID: 10083549
[No Abstract] [Full Text] [Related]
4. A sphingosine-1 phosphate agonist (FTY720) limits trauma/hemorrhagic shock-induced multiple organ dysfunction syndrome.
Bonitz JA; Son JY; Chandler B; Tomaio JN; Qin Y; Prescott LM; Feketeova E; Deitch EA
Shock; 2014 Nov; 42(5):448-55. PubMed ID: 25004059
[TBL] [Abstract][Full Text] [Related]
5. FTY720-induced lymphocyte homing modulates post-transplant preservation/reperfusion injury.
Dragun D; Böhler T; Nieminen-Kelhä M; Waiser J; Schneider W; Haller H; Luft FC; Budde K; Neumayer HH
Kidney Int; 2004 Mar; 65(3):1076-83. PubMed ID: 14871428
[TBL] [Abstract][Full Text] [Related]
6. FTY720 pretreatment reduces warm hepatic ischemia reperfusion injury through inhibition of T-lymphocyte infiltration.
Anselmo DM; Amersi FF; Shen XD; Gao F; Katori M; Lassman C; Ke B; Coito AJ; Ma J; Brinkmann V; Busuttil RW; Kupiec-Weglinski JW; Farmer DG
Am J Transplant; 2002 Oct; 2(9):843-9. PubMed ID: 12392290
[TBL] [Abstract][Full Text] [Related]
7. FTY720, a new class of immunomodulator, inhibits lymphocyte egress from secondary lymphoid tissues and thymus by agonistic activity at sphingosine 1-phosphate receptors.
Chiba K
Pharmacol Ther; 2005 Dec; 108(3):308-19. PubMed ID: 15951022
[TBL] [Abstract][Full Text] [Related]
8. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing.
Yanagawa Y; Masubuchi Y; Chiba K
Immunology; 1998 Dec; 95(4):591-4. PubMed ID: 9893050
[TBL] [Abstract][Full Text] [Related]
9. FTY720 reduces inflammation and promotes functional recovery after spinal cord injury.
Lee KD; Chow WN; Sato-Bigbee C; Graf MR; Graham RS; Colello RJ; Young HF; Mathern BE
J Neurotrauma; 2009 Dec; 26(12):2335-44. PubMed ID: 19624262
[TBL] [Abstract][Full Text] [Related]
10. FTY720 improves survival after transient ischemia and reperfusion of the hind limbs.
Frink M; Kaudel CP; Hildebrand F; Pape HC; Klempnauer J; Winkler M; Krettek C; van Griensven M
J Trauma; 2007 Aug; 63(2):263-7. PubMed ID: 17693822
[TBL] [Abstract][Full Text] [Related]
11. The sphingosine-1-phosphate receptor agonist FTY720 prevents the development of anti-glomerular basement membrane glomerulonephritis.
Sui M; Zhou J; Xie R; Liu X; Mu S; Jia X; Ma J; Wu H
Mol Biol Rep; 2012 Jan; 39(1):389-97. PubMed ID: 21833515
[TBL] [Abstract][Full Text] [Related]
12. FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats. I. FTY720 selectively decreases the number of circulating mature lymphocytes by acceleration of lymphocyte homing.
Chiba K; Yanagawa Y; Masubuchi Y; Kataoka H; Kawaguchi T; Ohtsuki M; Hoshino Y
J Immunol; 1998 May; 160(10):5037-44. PubMed ID: 9590253
[TBL] [Abstract][Full Text] [Related]
13. The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.
Murphy CT; Hall LJ; Hurley G; Quinlan A; MacSharry J; Shanahan F; Nally K; Melgar S
Infect Immun; 2012 Aug; 80(8):2712-23. PubMed ID: 22615252
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle arrest effects of large-dose FTY720 on lymphocytes in mouse skin transplantation models.
Li QY; Chi YY; Liu SQ
Immunopharmacol Immunotoxicol; 2008; 30(2):365-81. PubMed ID: 18569090
[TBL] [Abstract][Full Text] [Related]
15. Transient T cell accumulation in lymph nodes and sustained lymphopenia in mice treated with FTY720.
Morris MA; Gibb DR; Picard F; Brinkmann V; Straume M; Ley K
Eur J Immunol; 2005 Dec; 35(12):3570-80. PubMed ID: 16285007
[TBL] [Abstract][Full Text] [Related]
16. FTY720 attenuates hepatic ischemia-reperfusion injury in normal and cirrhotic livers.
Man K; Ng KT; Lee TK; Lo CM; Sun CK; Li XL; Zhao Y; Ho JW; Fan ST
Am J Transplant; 2005 Jan; 5(1):40-9. PubMed ID: 15636610
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of circulating lymphocyte counts in FTY720-treated MS patients.
Johnson TA; Shames I; Keezer M; Lapierre Y; Haegert DG; Bar-Or A; Antel J
Clin Immunol; 2010 Oct; 137(1):15-20. PubMed ID: 20599429
[TBL] [Abstract][Full Text] [Related]
18. Role of sphingosine 1-phosphate receptor type 1 in lymphocyte egress from secondary lymphoid tissues and thymus.
Chiba K; Matsuyuki H; Maeda Y; Sugahara K
Cell Mol Immunol; 2006 Feb; 3(1):11-9. PubMed ID: 16549044
[TBL] [Abstract][Full Text] [Related]
19. FTY720 attenuates accumulation of EMAP-II+ and MHC-II+ monocytes in early lesions of rat traumatic brain injury.
Zhang Z; Zhang Z; Fauser U; Artelt M; Burnet M; Schluesener HJ
J Cell Mol Med; 2007; 11(2):307-14. PubMed ID: 17488479
[TBL] [Abstract][Full Text] [Related]
20. The sphingosine 1-phosphate receptor agonist FTY720 differentially affects the sequestration of CD4+/CD25+ T-regulatory cells and enhances their functional activity.
Sawicka E; Dubois G; Jarai G; Edwards M; Thomas M; Nicholls A; Albert R; Newson C; Brinkmann V; Walker C
J Immunol; 2005 Dec; 175(12):7973-80. PubMed ID: 16339533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
